Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine in ESPB for Lumbar Fusion
NCT06231979Phase 4Not yet recruiting
- Sponsor
- Assiut University
- Start
- Feb 2024
- Primary completion
- Jan 2025
- Modality
- Small Molecules
01
Overview
Phase 4, randomised trial of dexmedetomidine in postoperative pain (2 arms), sponsored by Assiut University. Primary endpoint: Cumulative opioid consumption during first 48 h postoperatively. Planned start Feb 2024; status: not yet recruiting.
02
Drugs
dexmedetomidine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT06231979.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06231979.